FDA approves durvalumab for locally advanced or metastatic biliary tract cancer

Trial

TOPAZ-1

Drugs

Imfinzi (durvalumab) · Anti-PD-L1 antibody, gemcitabine · Pyrimidine analog, cisplatin · Platinum agent

Condition

Gastrointestinal